Royalty Pharma RPRX Stock
Royalty Pharma Price Chart
Royalty Pharma RPRX Financial and Trading Overview
| Royalty Pharma stock price | 31.79 USD |
| Previous Close | 32.15 USD |
| Open | 32.2 USD |
| Bid | 0 USD x 1300 |
| Ask | 0 USD x 1200 |
| Day's Range | 31.96 - 32.36 USD |
| 52 Week Range | 31.96 - 44.66 USD |
| Volume | 4.26M USD |
| Avg. Volume | 2.12M USD |
| Market Cap | 14.43B USD |
| Beta (5Y Monthly) | 0.424231 |
| PE Ratio (TTM) | 44.10959 |
| EPS (TTM) | 1.91 USD |
| Forward Dividend & Yield | 0.8 (2.46%) |
| Ex-Dividend Date | May 18, 2023 |
| 1y Target Est | 51.53 USD |
RPRX Valuation Measures
| Enterprise Value | 23.53B USD |
| Trailing P/E | 44.10959 |
| Forward P/E | 8.172589 |
| PEG Ratio (5 yr expected) | 1.27 |
| Price/Sales (ttm) | 6.1174946 |
| Price/Book (mrq) | 2.4245162 |
| Enterprise Value/Revenue | 9.973 |
| Enterprise Value/EBITDA | 19.879 |
Trading Information
Royalty Pharma Stock Price History
| Beta (5Y Monthly) | 0.424231 |
| 52-Week Change | -18.17% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 44.66 USD |
| 52 Week Low | 31.96 USD |
| 50-Day Moving Average | 34.43 USD |
| 200-Day Moving Average | 38.4 USD |
RPRX Share Statistics
| Avg. Volume (3 month) | 2.12M USD |
| Avg. Daily Volume (10-Days) | 2.87M USD |
| Shares Outstanding | 448.2M |
| Float | 384.64M |
| Short Ratio | 3.26 |
| % Held by Insiders | 24.84% |
| % Held by Institutions | 68.54% |
| Shares Short | 7.58M |
| Short % of Float | 1.77% |
| Short % of Shares Outstanding | 1.69% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.77 |
| Trailing Annual Dividend Yield | 2.39% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 1.0405 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 14.06% |
| Operating Margin (ttm) | 50.10% |
| Gross Margin | 64.45% |
| EBITDA Margin | 50.16% |
Management Effectiveness
| Return on Assets (ttm) | 4.28% |
| Return on Equity (ttm) | 6.12% |
Income Statement
| Revenue (ttm) | 2.36B USD |
| Revenue Per Share (ttm) | 5.35 USD |
| Quarterly Revenue Growth (yoy) | 21.69% |
| Gross Profit (ttm) | 1.33B USD |
| EBITDA | 1.18B USD |
| Net Income Avi to Common (ttm) | 331.83M USD |
| Diluted EPS (ttm) | 0.73 |
| Quarterly Earnings Growth (yoy) | 558.30% |
Balance Sheet
| Total Cash (mrq) | 1.98B USD |
| Total Cash Per Share (mrq) | 4.41 USD |
| Total Debt (mrq) | 7.12B USD |
| Total Debt/Equity (mrq) | 72.5 USD |
| Current Ratio (mrq) | 2.356 |
| Book Value Per Share (mrq) | 13.281 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 2.72B USD |
| Levered Free Cash Flow (ttm) | -1726824704 USD |
Profile of Royalty Pharma
| Country | United States |
| State | NY |
| City | New York |
| Address | 110 East 59th Street |
| ZIP | 10022 |
| Phone | 212 883 0200 |
| Website | https://www.royaltypharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Q&A For Royalty Pharma Stock
What is a current RPRX stock price?
Royalty Pharma RPRX stock price today per share is 31.79 USD.
How to purchase Royalty Pharma stock?
You can buy RPRX shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Royalty Pharma?
The stock symbol or ticker of Royalty Pharma is RPRX.
Which industry does the Royalty Pharma company belong to?
The Royalty Pharma industry is Biotechnology.
How many shares does Royalty Pharma have in circulation?
The max supply of Royalty Pharma shares is 576.45M.
What is Royalty Pharma Price to Earnings Ratio (PE Ratio)?
Royalty Pharma PE Ratio is 16.64398000 now.
What was Royalty Pharma earnings per share over the trailing 12 months (TTM)?
Royalty Pharma EPS is 1.91 USD over the trailing 12 months.
Which sector does the Royalty Pharma company belong to?
The Royalty Pharma sector is Healthcare.
Royalty Pharma RPRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16550.61 USD — |
-5.97
|
8.29B USD — | 16533.04 USD — | 16889.34 USD — | — - | 8.29B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4153.28 USD — |
+1.21
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 20257.83 USD — |
-5.96
|
— — | 20236.33 USD — | 20672.41 USD — | — - | — — |
| NASDAQ Q 50 NXTQ | 747.17 USD — |
-6.02
|
— — | 746.93 USD — | 767.65 USD — | — - | — — |
| Nasdaq Next Generation 100 Inde NGX | 1122.61 USD — |
-5.67
|
— — | 1122.22 USD — | 1150.94 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4130.78 USD — |
-1.87
|
— — | 4123.5 USD — | 4185.42 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 920.53 USD — |
-2.33
|
— — | 917.85 USD — | 930.28 USD — | — - | — — |
| Horizon Kinetics ISE Wealth Ind RCH | 3014.97 USD — |
-6.89
|
— — | 3014.4 USD — | 3145.66 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 8098.63 USD — |
-5.98
|
— — | 8089.65 USD — | 8265.47 USD — | — - | — — |
- {{ link.label }} {{link}}